Diversified Healthcare Q4 FFO Misses by 25%, Revenue Slides 4.5%
Diversified Healthcare reported Q4 FFO of $0.09 per share, missing the $0.12 consensus and compared with $0.02 a year earlier. Q4 revenue stood at $379.57 million, 4.5% below estimates and flat year-on-year, while shares have climbed 28.7% year-to-date.
1. Q4 Financial Results
Diversified Healthcare posted adjusted funds from operations of $0.09 per share for the quarter ended December 2025, falling 25% short of the $0.12 consensus. Revenue for the period reached $379.57 million, missing estimates by 4.5% and matching the prior year's $379.62 million.
2. Historical Comparison
The $0.09 FFO marked an improvement from $0.02 per share in Q4 2024 but undershot consensus for the fourth time in five quarters. Revenue has been largely stagnant over the past year, with this quarter representing the second revenue miss in four periods.
3. Stock Performance
Shares of Diversified Healthcare have surged 28.7% since January 1, outpacing the S&P 500’s 0.9% gain, reflecting investor optimism despite mixed operational results. Trading volumes have picked up around the earnings release as investors reassess valuation.
4. Forward Outlook
Current consensus forecasts call for Q1 FFO of $0.14 on $395.44 million in revenue and full-year FFO of $0.57 on $1.61 billion in revenue. The REIT and Equity Trust – Other industry sits in the bottom 35th percentile, underscoring the importance of operational execution for valuation.